Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Rocío Martín Lozano"'
Autor:
Rodrigo Sánchez-Bayona, Manuel Alva, Alfonso López de sa, Yolanda Jerez Gilarranz, Ana Sánchez de torre, Pablo Tolosa, Alicia de luna, Sara López-Tarruella, Laura Lema, Fernando Moreno, Isabel Echavarria, Ainhoa Madariaga, Javier Benítez, Blanca Herrero, Macarena Rey, Justo Ortega, Salvador Gámez, Andrea Modrego, Rocío Martín Lozano, Luis Figuero-Pérez, Roberto Jiménez, Marta González Sevilla, Irene González, Marianela Bringas Beranek, María de toro, Tatiana Massarrah, María del Monte-Millán, Marina Pinardo, Luis Manso, Coralia Bueno-Muiño, José Ángel García-Sáenz, Miguel Martín, Eva Ciruelos
Publikováno v:
Cancer Research. 83:P3-01
Introduction Since the approval a decade ago of everolimus in combination with endocrine therapy (ET), the treatment landscape of metastatic breast cancer (mBC) has changed dramatically. Endocrine monotherapy after progression to CDK4/6 inhibitors ha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9380e9f8a13c74c4eac93c5e3b4323c5
https://doi.org/10.1158/1538-7445.sabcs22-p3-01-04
https://doi.org/10.1158/1538-7445.sabcs22-p3-01-04
Autor:
Roberto Jiménez Rodríguez, Irene Gonzalez Caraballo, Rocío Martín Lozano, Manuel Alva Bianchi, Mónica Benavente de Lucas, María Palma Gómez, Marc Ariant Cañete Muñoz, Bárbara Lobato Delgado, Victoria Tirado Anula, Blanca Morón García, Magdalena Ruiz Zamorano, Ivan Marquez-Rodas, Isabel Echavarria Diaz Guardamino, Gabriela Torres Pérez-Solero, Aitana Calvo Ferrándiz, Laura Ortega, Jose Manuel Soria, Pilar Garcia-Alfonso, Miguel Martin, Andrés J. Muñoz Martín
Publikováno v:
Journal of Clinical Oncology. 41:670-670
670 Background: Pancreatic Ductal Adenocarcinoma (PDAC) has historically been an important diagnostic and therapeutic challenge. The multidisciplinary approach and new diagnostic techniques’ implementation have modified this process. Methods: We co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c7e993cd6ebdd6333d92e020f19e1e6b
https://doi.org/10.1200/jco.2023.41.4_suppl.670
https://doi.org/10.1200/jco.2023.41.4_suppl.670
Autor:
Javier Soto, Marianela Bringas, Natalia Gutiérrez Alonso, Andrés J. Muñoz Martín, Aitana Calvo Ferrándiz, Gabriela Torres Pérez-Solero, Laura Ortega, Rocío Martín Lozano, Roberto Jiménez Rodríguez, Irene Gonzalez Caraballo, Carlos López Jiménez, Ana Gutierrez Ortiz de la Tabla, David Salomon Juliao Caamaño, Marc Ariant Cañete Muñoz, Mónica Benavente de Lucas, María Palma Gómez, Manuel Alva Bianchi, Íñigo Martínez Delfrade, Miguel Martin, Pilar Garcia-Alfonso
Publikováno v:
Journal of Clinical Oncology. 41:66-66
66 Background: Patients with mCRC harboring BRAF mutation have worse prognosis and poor outcomes. However, those who have resectable metastatic disease and undergo surgery may have better outcomes compared to those who do not. Differences in clinical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::732381776c306df4420b30647dabbbb2
https://doi.org/10.1200/jco.2023.41.4_suppl.66
https://doi.org/10.1200/jco.2023.41.4_suppl.66
Autor:
Marianela Bringas, Javier Soto, Natalia Gutiérrez Alonso, Andrés J. Muñoz Martín, Aitana Calvo Ferrándiz, Gabriela Torres Pérez-Solero, Laura Ortega, Rocío Martín Lozano, Roberto Jiménez Rodríguez, Irene Gonzalez Caraballo, Ana Gutierrez Ortiz de la Tabla, Carlos López Jiménez, David Salomon Juliao Caamaño, María Palma Gómez, Mónica Benavente de Lucas, Marc Ariant Cañete Muñoz, Manuel Alva Bianchi, Íñigo Martínez Delfrade, Miguel Martin, Pilar Garcia-Alfonso
Publikováno v:
Journal of Clinical Oncology. 41:159-159
159 Background: Peritoneal metastases in patients with mCRC are commonly associated with poor outcomes. Some of these patients are candidates to undergo metastases surgery, which may result in better prognosis; however, clinical and molecular charact
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::83e31947cd3792b46d122d75a30716d9
https://doi.org/10.1200/jco.2023.41.4_suppl.159
https://doi.org/10.1200/jco.2023.41.4_suppl.159
Autor:
Rocío Martín Lozano, Roberto Jiménez Rodríguez, Irene Gonzalez Caraballo, Bárbara Lobato Delgado, María Palma Gómez, Marc Ariant Cañete Muñoz, Mónica Benavente de Lucas, Carlos López Jiménez, Victoria Tirado Anula, Blanca Morón García, María de Toro Carmena, Marianela Bringas Beranek, Javier Soto Alsar, Gabriela Torres Pérez-Solero, Aitana Calvo, Laura Ortega, Jose Manuel Soria, Pilar Garcia-Alfonso, Miguel Martin, Andrés J. Muñoz Martín
Publikováno v:
Journal of Clinical Oncology. 41:740-740
740 Background: Several inflammatory scores such as the Systemic Inflammation Response Index (SIRI), the Inflammation Index Score (IIS), and the Neutrophil Lymphocyte Ratio (NLR) have been reported to have prognostic value in PDAC with different resu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::36d0485dcbd175b20da5d4ba4fa137d6
https://doi.org/10.1200/jco.2023.41.4_suppl.740
https://doi.org/10.1200/jco.2023.41.4_suppl.740
Autor:
Pilar Garcia-Alfonso, Natalia Gutiérrez Alonso, Marianela Bringas Beranek, Javier Soto Alsar, Carlos López Jiménez, Ana Gutierrez Ortiz de la Tabla, Roberto Jiménez Rodríguez, Rocío Martín Lozano, César Gutiérrez Pérez, Manuel Alva Bianchi, Andrés J. Muñoz Martín, Gabriela Torres Pérez-Solero, Laura Ortega, Aitana Calvo Ferrándiz, Juan Luis Catoya Villa, Marta Arregui Valles, Inmaculada Aparicio Salcedo, Miguel Martin
Publikováno v:
Journal of Clinical Oncology. 40:e15552-e15552
e15552 Background: BRAF mutated mCRC patients have worse prognosis compared with BRAF wildtype mCRC. Within this group, those with resectable disease have a better prognosis compared to those with unresectable disease. However, it is not well known w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3cb5c3c9544c8385ff9e6f4ac79b502f
https://doi.org/10.1200/jco.2022.40.16_suppl.e15552
https://doi.org/10.1200/jco.2022.40.16_suppl.e15552
Autor:
Andrés J. Muñoz Martín, Laura Ortega Morán, Natalia Gutiérrez Alonso, Diego Megias, Ana Lopez-Alfonso, Maria del Monte Millán, Rebeca Bernat, Rocío Martín Lozano, Roberto Jiménez Rodríguez, Irene Gonzalez Caraballo, Lucía Villarejo López, Tatiana Massarrah, Gabriela Torres Pérez-Solero, Aitana Calvo Ferrándiz, Montserrat Blanco-Codesido, Pilar Garcia-Alfonso, Miguel Martin
Publikováno v:
Journal of Clinical Oncology. 40:586-586
586 Background: In recent years CTCs have been extensively studied in different neoplasms. However, in PC CTCs are still emerging as a potential prognostic tool and the significance in different stages of the disease and the correlation with tumor ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c837c939edc761e0b3bb82fe691432c
https://doi.org/10.1200/jco.2022.40.4_suppl.586
https://doi.org/10.1200/jco.2022.40.4_suppl.586
Autor:
Javier Soto, Natalia Gutiérrez Alonso, Marianela Bringas Beranek, Juan Luis Catoya Villa, Ana Gutierrez Ortiz de la Tabla, Carlos López Jiménez, Manuel Alva Bianchi, Roberto Jiménez Rodríguez, Rocío Martín Lozano, Marta Arregui Valles, Inmaculada Aparicio Salcedo, Laura Ortega Morán, Gabriela Torres Pérez-Solero, Andrés J. Muñoz Martín, Aitana Calvo Ferrándiz, Montserrat Blanco Codesido, Íñigo Martínez Delfrade, David Salomon Juliao Caamaño, Miguel Martin, Pilar Garcia-Alfonso
Publikováno v:
Journal of Clinical Oncology. 40:59-59
59 Background: Over the last decades the incidence of EOCRC (age 50 or less) has dramatically increased, and so has the scientific interest in this field, given that clinical and molecular characteristics in these patients are not well understood, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fc46382a590102442b8e2bb31f716e8c
https://doi.org/10.1200/jco.2022.40.4_suppl.059
https://doi.org/10.1200/jco.2022.40.4_suppl.059